EBAY
62
6
NTRS
64
-3
MU
62
-6
BF.B
59
-2
O
39
-11
CVS
39
-11
EOG
49
-3
HRL
35
12
AAL
51
-2
GD
57
-6
MCHP
49
-5
EQT
50
-4
EW
50
-3
MSI
35
-3
CHD
37
2
CSCO
60
-4
AZO
43
-2
NRG
50
-10
DAL
70
-3
USB
64
-2
EBAY
62
6
NTRS
64
-3
MU
62
-6
BF.B
59
-2
O
39
-11
CVS
39
-11
EOG
49
-3
HRL
35
12
AAL
51
-2
GD
57
-6
MCHP
49
-5
EQT
50
-4
EW
50
-3
MSI
35
-3
CHD
37
2
CSCO
60
-4
AZO
43
-2
NRG
50
-10
DAL
70
-3
USB
64
-2
Financhill
Back

ProShares S&P Kensho Cleantech ETF Vs. Nektar Therapeutics Sector Stock Comparison

Sell
50

CTEX
ProShares S&P Kensho Cleantech ETF

Last Price:
$37.70
Seasonality Move:
-8.49%
Sell
39

NKTR
Nektar Therapeutics

Last Price:
$54.70
Seasonality Move:
11.58%
Sell
50
ProShares S&P Kensho Cleantech ETF (CTEX) is a Sell

Is ProShares S&P Kensho Cleantech ETF a Buy, Sell or Hold?

  • The current ProShares S&P Kensho Cleantech ETF [CTEX] share price is $36.92. The Score for CTEX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • CTEX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $54.70. The Score for NKTR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CTEX Stock Price Chart

What is ProShares S&P Kensho Cleantech ETF's stock price today?

  • The ProShares S&P Kensho Cleantech ETF share price today is $36.92
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CTEX is experiencing selling pressure, which indicates risk of future bearish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $54.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

CTEX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.66 Buy
Relative Strength Index (14 RSI): 53.87 Buy
Chaikin Money Flow: -2875 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.64 - 38.02) Buy
Bollinger Bands (100): (26.23 - 36.39) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 141668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.71 - 61.07) Sell
Bollinger Bands (100): (32.74 - 62.56) Buy

CTEX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.13 Sell
20-day SMA: 35.28 Buy
50-day SMA: 35.86 Buy
200-day SMA: 25.38 Buy
8-day EMA: 37.08 Sell
20-day EMA: 36.25 Buy
50-day EMA: 34.37 Buy
200-day EMA: 20.23 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.42 Sell
20-day SMA: 58.12 Sell
50-day SMA: 58.41 Sell
200-day SMA: 30.65 Buy
8-day EMA: 56.16 Sell
20-day EMA: 57.43 Sell
50-day EMA: 55.78 Sell
200-day EMA: 37.86 Buy

ProShares S&P Kensho Cleantech ETF Earnings Growth & CTEX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

ProShares S&P Kensho Cleantech ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):